ACCREDITATION DOCUMENT

Transcription

1 Accreditation No: Awarded to Dow Diagnostic Reference and Research Laboratory (DDRRL), Dow University of Health Sciences Suparco Road Gulzar e Hijri KDA Scheme-35, Karachi, Pakistan. The scope of accreditation is in accordance with the standard specifications outlined in the following page(s) of this document. The accredited scope shall be visible and legible in areas such as customer service, sample-receiving section etc and shall not mislead its users. The accreditation was first time granted on by Pakistan National Accreditation Council. The laboratory complies with the requirements of ISO 15189:2012. The accreditation requires regular surveillance, and is valid until The decision of accreditation made by Pakistan National Accreditation Council implies that the organization has been found to fulfill the requirements for accreditation within the scope. The organization however, itself is responsible for the results of performed tests. PAKISTAN NATIONAL COUNCIL General Page 1 of 11

2 Medical Laboratory. Permanent laboratory Dow Diagnostic Reference and Research Laboratory (DDRRL), Dow University of Health Sciences Suparco Road Gulzar e Hijri KDA Scheme-35, Karachi. Field of Medical Testing Laboratory: Medical Testing Materials tested Testing field (e.g. Chemical, Micro etc) Types of test/ Properties measured Reference to standardized method/ Internal method reference Serum Microbiology ANTI HIV 1 & 2 Anti HBC HBCIgM RUBELLA IgG 10 IU/ml (positive) RUBELLA IgM HBeAg Page 2 of 11

3 HBeAb <1.0 (positive) HAV Total >20 IU/ml (positive) HAV IgM WBC x 10e3/ul Whole Blood Hematology RBC x 10e6/ul Hb g/dl HCT % MCV Fl Page 3 of 11

4 MCH pg MCHC g% RDW % PLT x 10 e3/ul MPV Fl ESR M=0-15 mm/hr F=0-22 mm/hr Serum Molecular Pathology HCV Qaulitative Test Positive/ Negative HCV Qauntitative / Viral Load HBV Qauntitative / Viral Load Upper quantification Limit > 100,000,000 Iu/ml Lowe quantification Limit <12 Iu/ml Upper quantification Limit >1,000,000,000 Iu/ml Lowe quantification Limit <10 Iu/ml Page 4 of 11

5 HCV Genotyping Genotype 1-6 Serum Chemical Pathology AFP < 8.5 ng/ml CA125 < 35 U/mL CEA Smoker < 5 Non Smoker < 3 CORTISOL M: ug/dl E: ug/dl FSH β-hcg Adult Male: Adult Female Follicular Phase: Mid Cycle Peak: Luteal Phase: Postmenopausal: Male And Non Pregnant Female: Pregnancy Week Of Gestational Ranges: 4 Weeks: Weeks Weeks miu/ Page 5 of 11

6 7-14 Weeks Weeks Weeks INSULIN 2 25 uiu/ml LH Adult Male: Adult Female Follicular Phase: Mid Cycle Peak: Luteal Phase: Postmenopausal: VALPROIC ACID ug/ml CARBAMEZEPINE 4 12 ug/ml PROLACTIN TOTAL PSA Male: ng/ml Female: ng/ml Pregnant Female: 3rd Trimester ng/ml 40-49yr ng/ml 50-59yrs ng/ml 60-69yrs ng/ml 70-79yrs ng/ml Page 6 of 11

7 FT3 Child and Adult pg/ml FT4 Newborn ng/ml Children ng/ml Adult ng/ml TT3 Adult nmol/l TT4 Adult Male ug/dl Adult Female TSH Vitamin D Birth 4days uiu/ml 2-20 Weeks uiu/ml 21 Weeks 20Yrs uiu/ml 21 54yrs uiu/ml 55-87yrs uiu/ml Vitanim D Deficiency < 10 ng/ml Vitamin D insufficiency ng/ml Vitamin D sufficiency >=30 ng/ml Vitamin D intoxication >150 ng/ml Vitamin B pg/ml Page 7 of 11

8 Ferritin IgE Adult Male ng/ml Adult Female ng/ml Newborn ng/ml 1 month ng/ml 2-5 Month ng/ml 6 Month ng/ml Neonates < 1.5 IU/mL 1yr < 15 IU/mL 1-- yrs < 60 IU/mL 6--9yrs < 92 IU/mL 10 15yrs< 200 IU/mL Adults 0 16 IU/mL Albumin g/dl ALT <34 uiu/ml ALP U/I AST < 31 U/I BILI TOTAL mg/ml BILI DIRECT mg/dl Page 8 of 11

9 CA mg/dl CHOL Desirable < 200mg/dL Borderline High mg/dl High > 239 mg/dl TG Normal < 150 mg/dl HDL Low < 40mg/dL High > 60 mg/dl Glucose (F) Normal < 100 mg/dl Impaired mg/dl Diabetes mellitus = > 126 mg/dl Urea mg/dL Creatinine mg/dl Total Protein g/dl GGT < 38 U/I Page 9 of 11

10 Amylase Total U/L Bicarbonate meq/l CK Total u/l IRON Newborn ug/dl Infant ug/dl Child ug/dl Male ug/dl Female ug/dl LDH u/l Lipase U/L Lithium meq/l Therapeutic Range MG mg/dl Phosphorus mg/dl Page 10 of 11

11 Uric Acid mg/dl Sodium meq/l Potasium meq/l Chloride meq/l Tissue Histopathology H&E NA* *NA= Not Applicable Page 11 of 11